Gala vs Sesame Care: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Sesame Care beats Gala overall, scoring 7.9/10 vs 7.2/10. Sesame Care is more affordable at $99/mo vs $149/mo. Choose Gala for tirzepatide-first patients who want a low-cost compounded pa. Choose Sesame Care for users who want cheap fda-approved brand-name glp-1 access ($.
A side-by-side comparison of Gala and Sesame Care covering pricing, scores, medication types, insurance, and more to help you decide.
Gala
#40 of 49Telehealth platform focused on compounded tirzepatide — both microdose and full-dose tiers — alongside a brand-name semaglutide (Ozempic) path and a 'coming soon' Wegovy pill. Operated by AI Coaching, Inc. (Wilmington, DE), backed by OpenLoop-affiliated medical groups (a recognized US telehealth backend) and LegitScript verified. Differentiator: a dedicated 'Gala GLP-1 Tracker' iOS + Android app for in-treatment dosing, weight, and side-effect logging.
Visit GalaSesame Care
#10 of 49Telehealth marketplace offering both a low-cost consultation model ($25/visit) and the new Success by Sesame membership program ($59/mo on 3/6/12-month plans) that bundles FDA-approved brand-name GLP-1 medications — including Foundayo (orforglipron), Wegovy pen and pill, and Zepbound.
Visit Sesame Care| Feature | Gala | Sesame Care |
|---|---|---|
| Our Score | 7.2/10 | 7.9/10 |
| Starting Price | $149/mo | $99/mo |
| Medication Type | Both | Both |
| Insurance Accepted | No | Yes |
| Best For | Tirzepatide-first patients who want a low-cost compounded path (microdose $149/mo or full-dose $179-199/mo) plus a dedicated iOS + Android tracker app for daily progress logging | Users who want cheap FDA-approved brand-name GLP-1 access ($149-349/mo Wegovy and Zepbound via Success by Sesame), or insured patients who just need a prescriber |
| Ranking | #40 | #10 |
Pros & Cons Compared
Gala
Pros
- +Microdose compounded tirzepatide at $149/mo — the cheapest microdose tirz on a tracked telehealth platform; full-dose compounded tirzepatide at $179/mo (yearly plan) or $199/mo (3-month plan)
- +Dedicated 'Gala GLP-1 Tracker' on BOTH iOS and Android — first-party in-treatment logging is uncommon among compounded-only platforms
- +OpenLoop-affiliated medical groups + LegitScript verification provide third-party accountability that many compounded-only platforms lack
- +All 50 states, free shipping, no insurance required, 24/7 patient support claimed
Cons
- −Brand-name Ozempic pricing ($1,299/mo) is materially above market — NovoCare direct pricing for Wegovy is $349/mo, Hers offers Wegovy at $149/mo via the 2026 Novo Nordisk partnership
- −Tirzepatide-only on the compounded side — compounded semaglutide is NOT offered, narrower medication menu than peers like Maximus, Ro, or Henry Meds
- −Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness — verify your specific dose and batch with each refill
- −Initial consultation typically a sync video visit, but ongoing follow-ups and questions are chat-based (no scheduled ongoing video access) — and no published labs, no named medical director, no specialty obesity oversight
- −Restrictive refund policy — Gala's published terms state 'IN NO EVENT SHALL YOU BE ISSUED A REFUND UPON CANCELLATION OF THE SUBSCRIPTION SERVICES' with a narrow exception for provider-initiated medical disqualification. No money-back guarantee. Read the published policy at galaglp1.com/refund-policy before enrolling on a commitment plan
- −Newer brand under AI Coaching, Inc. (founded 2024 per LinkedIn) — limited public company history; founders, founding year, and named medical director not publicly disclosed on galaglp1.com itself
Sesame Care
Pros
- +Success by Sesame program launched 2026 — $59/mo on a 3/6/12-month plan, bundles labs, unlimited messaging, and provider choice
- +Brand-name cash pricing is competitive — Wegovy pen $199 intro / $349 ongoing, Zepbound vial $299, Wegovy pill $149
- +Foundayo (Lilly's FDA-approved oral GLP-1) available as of April 2026 at $149/mo
- +Original pay-per-visit model still available at $25/consultation for users who just need a prescriber
Cons
- −Membership model adds complexity — two distinct products (pay-per-visit vs Success membership) can be confusing
- −Success by Sesame requires a 3-month minimum commitment to hit the $59/mo rate
- −Compounded meds are de-emphasized on the current marketing — focus has shifted to FDA-approved brand-name paths
- −Less hand-holding than dedicated subscription platforms like Willow or Sprout Health
Our Verdict
Sesame Care edges out Gala with a score of 7.9/10 vs 7.2/10. If budget is your priority, Sesame Care starts at $99/mo compared to Gala's $149/mo. Sesame Care accepts insurance, which can significantly reduce your out-of-pocket costs. Choose Gala if you want: tirzepatide-first patients who want a low-cost compounded path (microdose $149/mo or full-dose $179-199/mo) plus a dedicated ios + android tracker app for daily progress logging. Choose Sesame Care if you want: users who want cheap fda-approved brand-name glp-1 access ($149-349/mo wegovy and zepbound via success by sesame), or insured patients who just need a prescriber.
Still undecided? Editor's #1 Overall Pick
Embody
$299/mo · 7.3/10 · Compounded
If neither Gala nor Sesame Care feels like the right fit, our overall #1 pick across all 49 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.
Read Full Reviews
Related comparisons
Other matchups readers comparing Gala or Sesame Care tend to look at next.
- Gala vs TMates$158/mo
- Gala vs FeelGood$149/mo
- Gala vs Oak Longevity$130/mo
- Sesame Care vs Hers$199/mo
- Sesame Care vs Found$264/mo
- Sesame Care vs Oak Longevity$130/mo